Figure 1.
Clinical history of an exceptional responder to combined MAPK and PI3K inhibition. A, Graphical description of clinical events. B, Radiographic documentation of response. The patient’s tumor continued to grow through everolimus and dabrafenib monotherapies individually. When combined, the patient’s tumor showed a dramatic response.